Authors: KLAASSEN RJL VANGELDER T DEMEESTER J DEINUM J WEIMAR W

Citation: Rjl. Klaassen et al., INCIDENCE OF POSTTRANSPLANT ERYTHROCYTOSIS (PTE) IN KIDNEY GRAFT RECIPIENTS WHERE THE RECIPIENT OF THE CONTRALATERAL KIDNEY DEVELOPED PTE, Transplantation, 65(8), 1998, pp. 1138-1139

Authors: GREGOOR PJHS VANGELDER T TANIS AA CHADHAAJWANI S KLAASSEN RJL WEIMAR W

Citation: Pjhs. Gregoor et al., CYTOMEGALOVIRUS COLITIS IN A CMV-SEROPOSITIVE RENAL-TRANSPLANT RECIPIENT ON TRIPLE-DRUG THERAPY (INCLUDING MYCOPHENOLATE), Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2766-2767

Authors: KLAASSEN RJL VANGELDER T RISCHENVOS J DEINUM J TVELD AJMI WEIMAR W

Citation: Rjl. Klaassen et al., LOSARTAN, AN ANGIOTENSIN-II (ANG-II) RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS (HET) IN PATIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS (PTE), Kidney international, 52(2), 1997, pp. 562-562

Authors: KLAASSEN RJL VANGELDER T RISCHENVOS J DEINUM J MANINTVELD AJ WEIMAR W

Citation: Rjl. Klaassen et al., LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST REDUCES HEMATOCRITS IN KIDNEY-TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS, Transplantation, 64(5), 1997, pp. 780-782

Authors: VANGELDER T KLAASSEN RJL VANRIEMSDIJKVANOVERBEEKE IC IJZERMANS JNM WEIMAR W

Citation: T. Vangelder et al., MYCOPHENOLATE MOFETIL AND PREDNISONE AS MAINTENANCE TREATMENT AFTER KIDNEY-TRANSPLANTATION, Transplantation, 63(10), 1997, pp. 1530-1531

Authors: KLAASSEN RJL TROOST RJJ VERHOEVEN GT KREPEL HP VANDERLELY AJ

Citation: Rjl. Klaassen et al., SUGGESTIVE EVIDENCE FOR BROMOCRIPTINE-INDUCED PLEURISY, Netherlands journal of medicine, 48(6), 1996, pp. 232-236